• 10.01.2020 – 12:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie GmbH enforces its patents in the field of human milk oligosaccharides against Nestlé in Germany

  Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH filed a patent infringement suit with the regional court in Mannheim on January 09, 2020 against Nestlé Nutrition GmbH and its holding company Nestlé Deutschland AG. Nestlé offers its infant formula Beba Supreme which contains two human milk oligosaccharides - ...

  more

• 08.01.2020 – 17:00

  Jennewein Biotechnologie GmbH

  Publication of a toxicological study: a milestone for Jennewein Biotechnologie for the GRAS approval of the HMO-mix

  Rheinbreitbach (ots) - Jennewein Biotechnology announces another milestone in the Worldwide approval of a new product generation, the "HMO-Mix". The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats", was recently accepted for publication by the ...

  more

• 25.11.2019 – 12:29

  AGRANA Beteiligungs-AG

  EANS-News: € 100 million investment: AGRANA opens second wheat starch plant at site in Pischelsdorf (Lower Austria) - IMAGE

  http://resources.euroadhoc.com/images/2118/5/10381423/AGRANA_Banddurchschneidung_Pischelsdorf.jpg issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Berlin, ...

  more

• 25.11.2019 – 10:13

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie obtains US-FDA GRAS status on alternative 2'-fucosyllactose fermentation strain

  Rheinbreitbach (ots) - Jennewein Biotechnologie GmbH, Rheinbreitbach, the leading manufacturer of human milk oligosaccharides (HMOs), announces that the U.S. Food and Drug Administration (FDA) issued a "no question" response letter to Jennewein's supplement of its GRAS Notice GRN571, thereby acknowledging that the ...

  more

• 25.11.2019 – 10:02

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie sues Glycom for patent infringement in Denmark

  Rheinbreitbach (ots) - Jennewein Biotechnologie develops fermentative processes for manufacturing of human milk oligosaccharides (HMOs) cost efficiently in an industrial scale since 2005 to make these special sugars available for affordably priced infant formula and other uses in food. Jennewein Biotechnologie was the first commercial vendor of HMOs, and brought the ...

  more

• 18.09.2019 – 11:04

  Brenntag AG

  Brenntag and Corbion strengthen their partnership in EMEA

  Dear all, Please find attached Brenntag's press release regarding the signing of an enhanced framework agreement with Corbion, strengthening the companies' long-time partnership in the EMEA region. For further information please see the press release. Please do not hesitate to contact us if you have further questions. Best regards, Hubertus Spethmann Essen, September 18, 2019 Brenntag and Corbion strengthen their ...

  more

• 11.09.2019 – 17:00

  Jennewein Biotechnologie GmbH

  Administrative Law Judge issues ruling in patent dispute concerning 2'-FL production and beta-galactosidase activity

  Rheinbreitbach (ots) - On September 09, 2019, Administrative Law Judge Cameron Elliot of the US International Trade Commission issued an Initial Determination finding that one of the bacterial strains used by Jennewein Biotechnologie to make 2'-fucosyllactose (2'-FL) infringes a patent owned by Glycosyn LLC. In the ...

  more

• 27.02.2019 – 09:18

  nova-Institut GmbH

  

  PRESS RELEASE (DE/EN): The "Top 6" candidates are nominated for the first innovation award "Best CO2 Utilisation 2019"

  more

• 20.02.2019 – 19:02

  Novasep

  Novasep Announces the Success of Its Consent Solicitation Extending the Maturity of Its Notes

  Lyon, France (ots/PRNewswire) - - All resolutions were approved by 100% of the participating Noteholders and C Warrantholders - Noteholders representing 99.9% of total outstanding principal amount participated Novasep Holding S.A.S ("Novasep"), a leading supplier of services and technologies for the life sciences industry, is pleased to announce that the consent ...

  more

• 05.02.2019 – 10:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market

  Hohhot, China & Rheinbreitbach, Germany (ots) - - China represents the largest market for baby food globally - Human milk oligosaccharides are key for the development of a healthy infant microbiome Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO), ...

  more

• 31.01.2019 – 16:34

  Novasep

  Novasep Announces the Launch of a Consent Solicitation for the Maturity Extension of Notes with Requisite Voting Majority of the Noteholders Already Secured

  Lyon, France (ots/PRNewswire) - Novasep Holding S.A.S ("Novasep"), a leading supplier of services and technologies for the life sciences industry, announces the launch of a consent solicitation (the "Consent Solicitation") in order to, inter alia : - extend the maturity of the senior notes in an initial aggregate ...

  more

• 08.10.2018 – 14:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie GmbH acquires Arthus Mineralsprings Bad Hönningen to build a new integrated fermentation and recovery plant for human milk oligosaccharides

  Rheinbreitbach/Germany (ots) - Jennewein Biotechnologie GmbH announces that it has acquired the former facilities of Arthus Mineralspring Company in Bad Hönningen (Rhineland-Palatine) in order to expand the production of human milk oligosaccharides (HMOs). "We have been searching for some time for a suitable ...

  more

• 05.07.2018 – 12:00

  Jennewein Biotechnologie GmbH

  Jennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany

  Rheinbreitbach (ots) - Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms. "The relocation of part of our ...

  more